Literature DB >> 14662965

Multilocus sequence typing of Candida glabrata reveals geographically enriched clades.

Andrew R Dodgson1, Claude Pujol, David W Denning, David R Soll, Andrew J Fox.   

Abstract

The haploid pathogenic yeast Candida glabrata is the second most common Candida species isolated from cases of bloodstream infection. The clinical relevance of C. glabrata is enhanced by its reduced susceptibility to fluconazole. Despite this, little is known of the epidemiology or population structure of this species. We developed a multilocus sequence typing (MLST) scheme for C. glabrata and used it to fingerprint a geographically diverse collection of 107 clinical isolates and 2 reference strains. Appropriate loci were identified by amplifying and sequencing fragments of the coding regions of 11 C. glabrata genes in 10 unrelated isolates. The 6 most variable loci (FKS, LEU2, NMT1, TRP1, UGP1, and URA3) were sequenced in the collection of 109 isolates. From the 3,345 bp sequenced in each isolate, 81 nucleotide sites were found to be variable. These defined 30 STs among the 109 strains. The technique was validated by comparison with random amplified polymorphic DNA and the complex DNA fingerprinting probes Cg6 and Cg12. MLST identified 5 major clades among the isolates studied. Three of the clades exhibited significant geographical bias. Our data demonstrate for the first time, with such a large geographically diverse strain collection, that distinct genetic clades of C. glabrata prevail in different geographical regions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662965      PMCID: PMC309006          DOI: 10.1128/JCM.41.12.5709-5717.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone.

Authors:  M C Enright; B G Spratt; A Kalia; J H Cross; D E Bessen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 2.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Induction of mating in Candida albicans by construction of MTLa and MTLalpha strains.

Authors:  B B Magee; P T Magee
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

4.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Typing of Candida glabrata in clinical isolates by comparative sequence analysis of the cytochrome c oxidase subunit 2 gene distinguishes two clusters of strains associated with geographical sequence polymorphisms.

Authors:  G F Sanson; M R Briones
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Multilocus sequence typing system for Campylobacter jejuni.

Authors:  K E Dingle; F M Colles; D R Wareing; R Ure; A J Fox; F E Bolton; H J Bootsma; R J Willems; R Urwin; M C Maiden
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host.

Authors:  C M Hull; R M Raisner; A D Johnson
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

8.  Candida glabrata displays pseudohyphal growth.

Authors:  C Csank; K Haynes
Journal:  FEMS Microbiol Lett       Date:  2000-08-01       Impact factor: 2.742

9.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Authors:  M B Edmond; S E Wallace; D K McClish; M A Pfaller; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

10.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.

Authors:  M C Enright; N P Day; C E Davies; S J Peacock; B G Spratt
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

View more
  72 in total

1.  Haploidy, diploidy and evolution of antifungal drug resistance in Saccharomyces cerevisiae.

Authors:  James B Anderson; Caroline Sirjusingh; Nicole Ricker
Journal:  Genetics       Date:  2004-09-15       Impact factor: 4.562

2.  Breakthrough invasive candidiasis in patients on micafungin.

Authors:  Christopher D Pfeiffer; Guillermo Garcia-Effron; Aimee K Zaas; John R Perfect; David S Perlin; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

3.  MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata.

Authors:  Pilar Escribano; Jesús Guinea; María Ángeles Bordallo-Cardona; Caroline Agnelli; Ana Gómez-Nuñez; Carlos Sánchez-Carrillo; Emilio Bouza; Patricia Muñoz
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

4.  Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan.

Authors:  Kuo-Wei Chen; Yee-Chun Chen; Hsiu-Jung Lo; Frank C Odds; Tzu-Hui Wang; Chi-Yang Lin; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

5.  Molecular phylogenetics of Candida albicans.

Authors:  Frank C Odds; Marie-Elisabeth Bougnoux; Duncan J Shaw; Judith M Bain; Amanda D Davidson; Dorothée Diogo; Mette D Jacobsen; Maud Lecomte; Shu-Ying Li; Arianna Tavanti; Martin C J Maiden; Neil A R Gow; Christophe d'Enfert
Journal:  Eukaryot Cell       Date:  2007-04-06

Review 6.  Multilocus sequence typing of pathogenic Candida species.

Authors:  Frank C Odds; Mette D Jacobsen
Journal:  Eukaryot Cell       Date:  2008-05-02

7.  Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.

Authors:  John D Cleary; Guillermo Garcia-Effron; Stanley W Chapman; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

8.  Clinical and microbiological investigation of fungemia from four hospitals in China.

Authors:  Danfeng Dong; Zhen Li; Lihua Zhang; Cen Jiang; Enqiang Mao; Xuefeng Wang; Yibing Peng
Journal:  Mycopathologia       Date:  2015-02-27       Impact factor: 2.574

9.  ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait.

Authors:  Suhail Ahmad; Leena Joseph; Josie E Parker; Mohammad Asadzadeh; Steven L Kelly; Jacques F Meis; Ziauddin Khan
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

10.  One year prospective survey of Candida bloodstream infections in Scotland.

Authors:  Frank C Odds; Mary F Hanson; Amanda D Davidson; Mette D Jacobsen; Pauline Wright; Julie A Whyte; Neil A R Gow; Brian L Jones
Journal:  J Med Microbiol       Date:  2007-08       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.